ABL Bio-Technologies Ltd

ABL Bio-Tech. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

ABL Bio-Technologies Ltd

₹ 0.81 3.85%
11 Jul 2016
ablbiotechnologies.com BSE: 526955
About

ABL Bio Technologies Limited is an India-based company. The company is engaged in bio technology industry.

[ add key points ]
Website BSE
  • Market Cap ₹ 0.66 Cr.
  • Current Price ₹ 0.81
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ 21.9
  • Dividend Yield 0.00 %
  • ROCE -0.50 %
  • ROE -0.97 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.04 times its book value

Cons

  • Company has low interest coverage ratio.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015 Jun 2015 Sep 2015 Dec 2015 Mar 2016
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02
Operating Profit -0.01 -0.02 -0.02 -0.01 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02
OPM % -100.00%
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02
Profit before tax -0.03 -0.04 -0.04 -0.03 -0.04 -0.04 -0.04 -0.04 -0.04 -0.04 -0.04 -0.04 -0.04
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-0.04 -0.04 -0.04 -0.04 -0.04 -0.04 -0.04 -0.04 -0.04 -0.04 -0.03 -0.03 -0.03
EPS in Rs -0.05 -0.05 -0.05 -0.05 -0.05 -0.05 -0.05 -0.05 -0.05 -0.05 -0.04 -0.04 -0.04
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 TTM
0.04 0.00 0.00
0.57 0.12 0.08
Operating Profit -0.53 -0.12 -0.08
OPM % -1,325.00%
0.00 0.01 0.00
Interest 0.00 0.00 0.00
Depreciation 0.07 0.07 0.08
Profit before tax -0.60 -0.18 -0.16
Tax % 0.00% 0.00%
-0.60 -0.18 -0.13
EPS in Rs -0.73 -0.22 -0.17
Dividend Payout % 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -100%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 19%
Stock Price CAGR
10 Years: -9%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: -1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012
Equity Capital 8.20 8.20
Reserves 10.54 10.36
16.96 17.10
9.54 9.58
Total Liabilities 45.24 45.24
34.86 34.80
CWIP 0.00 0.00
Investments 1.30 1.30
9.08 9.14
Total Assets 45.24 45.24

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012
Net Cash Flow

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012
Debtor Days 2,920.00
Inventory Days 0.00
Days Payable
Cash Conversion Cycle 2,920.00
Working Capital Days -8,942.50
ROCE % -0.50%

Shareholding Pattern

Numbers in percentages

Jun 2016
0.60%
6.35%
4.54%
88.51%
No. of Shareholders 3,957

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports